Twist Bioscience Corporat... (TWST)
undefined
undefined%
At close: undefined

Company Description

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products.

The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip.

It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium.

The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools.

It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets.

Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Twist Bioscience Corporation
Twist Bioscience Corporation logo
Country United States
IPO Date Oct 31, 2018
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 919
CEO Dr. Emily Marine Leproust Ph.D.

Contact Details

Address:
681 Gateway Boulevard
South San Francisco, California
United States
Website https://www.twistbioscience.com

Stock Details

Ticker Symbol TWST
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001581280
CUSIP Number 90184D100
ISIN Number US90184D1000
Employer ID 46-2058888
SIC Code 2836

Key Executives

Name Position
Dr. Emily Marine Leproust Ph.D. Co-Founder, Chairman & Chief Executive Officer
Adam Laponis Chief Financial Officer
Dennis Cho J.D. Senior Vice President, Chief Legal Officer & Corporate Secretary
Dr. Michael Fero Ph.D. Chief Information Officer
Dr. Patrick John Finn Ph.D. President & Chief Operating Officer
Siyuan Chen Chief Technology Officer
Dr. Aaron K. Sato Ph.D. Chief Scientific Officer
Dr. William Charles Banyai Ph.D. Senior Vice President of Advanced Development, GM of Data Storage & Director
Paula Green Senior Vice President of Human Resources
Robert F. Werner Vice President & Chief Accounting Officer

Latest SEC Filings

Date Type Title
Dec 10, 2024 4 Filing
Dec 10, 2024 4 Filing
Dec 10, 2024 4 Filing
Dec 10, 2024 4 Filing
Dec 06, 2024 4 Filing
Dec 06, 2024 4 Filing
Dec 06, 2024 4 Filing
Dec 06, 2024 4 Filing
Dec 06, 2024 4 Filing
Dec 06, 2024 4 Filing